MedPath

MINNESOTA EYE CONSULTANTS, P.A.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:1

Trial Phases

2 Phases

Phase 4:1
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (50.0%)
Phase 4
1 (50.0%)

Ocular Comfort and Inflammation in Lid Hygiene Therapy

Not Applicable
Terminated
Conditions
Blepharitis
First Posted Date
2016-10-19
Last Posted Date
2020-08-20
Lead Sponsor
Minnesota Eye Consultants, P.A.
Target Recruit Count
14
Registration Number
NCT02938078
Locations
🇺🇸

Minnesota eye Consultants, PA, Bloomington, Minnesota, United States

The Effect of BEPREVE 1.5% on Tear Film Osmolarity and Tear Film Lipid Layer

Phase 4
Completed
Conditions
Allergic Conjunctivitis
Interventions
Drug: Refresh Tears 0.5% Lubricant Eye Drops
First Posted Date
2011-05-03
Last Posted Date
2020-03-31
Lead Sponsor
Minnesota Eye Consultants, P.A.
Target Recruit Count
40
Registration Number
NCT01346371
Locations
🇺🇸

Minnesota Eye Consultants, P.A., Minneapolis, Minnesota, United States

News

No news found
© Copyright 2025. All Rights Reserved by MedPath